1-3 of 3
Josef Birkmann, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rituximab and Bendamustine for First-Line Treatment of Frail or Elderly Patients with Aggressive B-Cell Lymphoma: Final Results of the Prospective Phase-II Brenda Trial of GLA (German Lymphoma Alliance)

Florian Zettl, Friederike Braulke, Marita Ziepert, PhD, Andreas Viardot, MD PhD, Christoph Kahl, MD, Gabriele Prange-Krex, Agnieszka Korfel, Martin H. Dreyling, MD PhD, Thomas Illmer, MD, Josef Birkmann, MD, Ulrich Wedding, Dietmar Reichert, Maike de Wit, MD, Frank Hartmann, MD, Hans-Juergen Hurtz, Norbert Schmitz, MD, Mathias Witzens-Harig, MD, Wolfram Klapper, Andreas Rosenwald, MD, Viola Poeschel, MD, Markus Loeffler, MD, Gerald Wulf, MD, Bettina Altmann, PhD, Lorenz Truemper, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4073.
https://doi.org/10.1182/blood-2019-122948
Published: 2019
Journal Articles

Clinical-Scale Combined CD4/CD8 Depletion for Donor Innate Lymphocyte Infusion (DILI).

Volker Kunzmann, MD, Manfred Smetak, PhD, Florian Weissinger, MD, Josef Birkmann, MD, Hermann Einsele, MD, Martin Wilhelm, MD
Journal: Blood
Blood (2006) 108 (11): 3657.
https://doi.org/10.1182/blood.V108.11.3657.3657
Published: 2006
Journal Articles

γδ T Cell-Mediated Immunotherapy of Malignancies with Zoledronate and IL-2.

Volker Kunzmann, MD, Manfred Smetak, PhD, Brigitte Kimmel, PhD, Florian Weissinger, MD, Karin Weigang-Koehler, MD, Josef Birkmann, MD, Hermann Einsele, MD, Martin Wilhelm, MD
Journal: Blood
Blood (2005) 106 (11): 2439.
https://doi.org/10.1182/blood.V106.11.2439.2439
Published: 2005